As per Fortune Business Insights’ report, the U.S. botulinum toxin Market share sector attained a worth of USD 4.58 billion in 2022. Forecasts indicate a promising path ahead, foreseeing a Compound Annual Growth Rate (CAGR) of 5% from 2022 to 2030. This trajectory will culminate in a noteworthy achievement of USD 6.68 billion by 2030, highlighting considerable opportunities within this […]


